To allow for a complete analysis, CRC samples (n = 2) and control samples (n = 1) that had an invalid ACTB in one of the two multiplexes, were discarded in this process which resulted in a total of 43 CRC and 42 control urine supernatants to be evaluated. The gene discussed is ACTB; the disease is colorectal carcinoma.